Efficacy and safety of everolimus in korean patients with metastatic renal cell carcinoma following treatment failure with a vascular endothelial growth factor receptor-tyrosine kinase inhibitor.

Cancer Res Treat · 2014 · PMC4206076 · PMID 25036572

Europe PMC DOI

hedged sentence

0.1010

closest p · 2.0× alpha

0.1010

boldest claim

The sentences

only marginally significantp=0.101not close (p > 0.1)

Only development of hyperglycemia during everolimus treatment showed significant correlation with a favorable PFS (HR, 0.57; p=0.025), while anemia was only marginally significant (HR, 0.65; p=0.101) ( Table 5 ).

also in 5,076 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.